A father picks up his young child and give them a kiss.

Financial Story

Investors

Path to grow: Reset. Strengthen. Strive.

Investors > Overview
Latest News
Apr 22, 2024
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven lots of Treprostinil Injection...

Apr 11, 2024
Endo, Inc. Announces Pricing of $1.5 billion of Senior Secured Term Loan as Part of Endo's $2.5 billion Exit Financing

Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Borrower") priced its $1,500.0 million senior secured seven-year term...

Apr 11, 2024
Endo, Inc. Announces Pricing of $1.0 billion of Senior Secured Notes

Endo, Inc. ("Endo"), a newly formed entity, today announced that its wholly-owned subsidiary Endo Finance Holdings, Inc. (the "Issuer") priced $1,000.0 million aggregate principal amount of its...

View All Press Releases

Our Board

Governance

Endo’s board of directors oversees and advises our leaders to protect the long-term interests of the company and our shareholders. The experienced and independent board members are committed to building sustainable success.

Directors

Overview

This is body copy - it will be turned off in site mgr